Filing Details
- Accession Number:
- 0001104659-20-096109
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-08-17 16:17:16
- Reporting Period:
- 2020-08-13
- Accepted Time:
- 2020-08-17 16:17:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1613859 | Pra Health Sciences Inc. | PRAH | Services-Commercial Physical & Biological Research (8731) | 463640387 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1624044 | L Christopher Gaenzle | C/O Pra Health Sciences, Inc. 4130 Parklake Avenue, Suite 400 Raleigh NC 27612 | Evp, Cao & General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-08-13 | 1,364 | $102.88 | 37,636 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Represents the number of shares required to be sold by the reporting person to satisfy tax withholding obligations related to the vesting of 4,500 shares of restricted stock from an August 13, 2019 grant of 9,000 shares of restricted stock. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.